PharmacoEconomics & Outcomes News Weekly

, Volume 158, Issue 1, pp 8–8 | Cite as

Acarbose reduces bodyweight gain and CHD costs in type 2 diabetes

Newsletter Article


Coronary Heart Disease Glibenclamide Acarbose Coronary Heart Disease Event Bodyweight Gain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1998

Personalised recommendations